Navigation Links
Keeneland Project deploys new GPU supercomputing system for the National Science Foundation
Date:11/14/2012

en received from XSEDE application users.

"Our Keeneland Initial Delivery system has hosted over 130 projects and 200 users over the past two years," says Vetter. "Requests for access to Keeneland have far outstripped the planned resource delivery, sometimes by as much as twice the availability."

The Keeneland Project is a five-year Track 2D cooperative agreement, which was awarded by NSF under Contract OCI-0910735 in 2009 for the deployment of an innovative high performance computing system to the open science community. The Georgia Institute of Technology, University of Tennessee-Knoxville, the National Institute for Computational Sciences, and Oak Ridge National Laboratory manage the facility, perform education and outreach activities for advanced architectures, develop and deploy software tools for this class of architecture to ensure productivity, and team with early adopters to map their applications to Keeneland architectures.


'/>"/>

Contact: Joshua Preston
jpreston@cc.gatech.edu
678-231-0787
Georgia Institute of Technology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Gene sequencing project identifies abnormal gene that launches rare childhood leukemia
2. Devotes, a project to investigate marine biodiversity and the environment of European seas
3. Global Market for Blood Banking and Blood Products Projected to reach $43 billion by 2018; Spectrometers and Fluorometers to Reach $18.4 bn; Anticoagulants to Reach $12.9 bn; Cell and Tissue Culture Supplies to Reach $5.6 bn
4. Smithsonian launches global marine biodiversity project with $10 million donation
5. Novel plastic-and-papyrus restoration project
6. NIH New Innovator Award helps Sanford-Burnham scientist pursue high-risk, high-reward project
7. CNIO participates in the ENCODE project: A stride forward in biomedical research
8. AZTI-Tecnalia leads 2 research projects on bluefin tuna with 1.5 million euros investment
9. The ENCODE Project publishes new genomic insights in special issue of Genome Research
10. Concern about plans to close unique Canadian environmental project
11. Global Biobanking Market Projected to Increase by 30% to Reach $183 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2014)... School of Medicine announced today that it is ... by the Bill & Melinda Gates Foundation. ... and Reproductive Sciences; and Vice Chair of Research ... Medicine will pursue an innovative global health and ... Assess Fetal Neurodevelopment.", Grand Challenges Explorations (GCE) funds ...
(Date:11/4/2014)... of Madagascar,s 101 species of lemurs are threatened with ... rainforests they call home. A new study by Rice ... on rainforest tree populations, which raises concerns about the ... rich biodiversity. , A large proportion of trees in ... in turn disperse the seeds of their fruit trees ...
(Date:11/3/2014)... , Nov. 3, 2014  NeuroSigma ® ... -based life sciences company focused on commercialization of ... for the treatment of neurological and neuropsychiatric ... Industrial Property has issued a Notice of Allowance ... application is co-owned by NeuroSigma and the Regents ...
Breaking Biology News(10 mins):Temple University School of Medicine receives Grand Challenges Explorations grant 2Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
... in a virtual reality forest, will anyone hear an environmental message? ... cut down the make-believe redwood. New findings from Stanford researchers ... and told to saw through a towering sequoia until it crashed ... world than people who only imagined what it,s like to cut ...
... ST. LOUIS Saint Louis University researchers have identified ... fluid from tissues to lymphatic vessels. It may be possible ... organ to another organ and improve the effectiveness of vaccines. ... consisting of vessels in the body. It defends the body ...
... research by scientists at The Scripps Research Institute and collaborating ... that may provide a target for obesity and diabetes drugs. ... Cell Metabolism , the scientists describe a protein called ... signals that stimulate fat cell formation and turn off those ...
Cached Biology News:Stanford's virtual reality lab focuses on conservation 2Stanford's virtual reality lab focuses on conservation 3Outsmarting cancer cells: SLU scientists learn how they spread 2Scripps Research scientists find 'dual switch' regulates fat formation 2Scripps Research scientists find 'dual switch' regulates fat formation 3
(Date:11/22/2014)... MA (PRWEB) November 21, 2014 ... key investors will gather on December 3rd at ... Biotech Conferences series. GeneticRx will take place at ... Medical School and will discuss the present and ... therapy, exon skipping, and gene editing—as well as ...
(Date:11/22/2014)... November 21, 2014 RURO, Inc., ... provider, has released Limfinity® version 5.1.4. , RURO’s ... of Limfinity® than ever in RURO’s 8 year ... minority framework enhancement. Limfinity® version 5.1.4 is the ... and beyond bug fixes! , Limfinity® 5.1.4 release ...
(Date:11/22/2014)... 2014 The “Chiral Chromatography Columns ... Material (Metal, Glass, Plastic), by Application [GC, LC ... Forecast to 2018” analyses and studies the major ... America, Europe, Asia, and Rest of the World. ... figures spread through 135 pages and in-depth TOC ...
(Date:11/22/2014)... 2014  The element of surprise has been a ... strike without warning. Until now, epidemiologists had nothing to ... outbreak, resulting in suboptimal responses to both the H1N1 ... Photo - http://photos.prnewswire.com/prnh/20141121/160242 ... because virus gene structural changes have been found that ...
Breaking Biology Technology:Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2RURO Announces Limfinity® version 5.1.4 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5Viruses' Advantage of Surprise is Lost 2
... , SAN DIEGO, Calif., July ... and its subsidiary Tissue Repair Company (TRC) today provided an ... study and announced plans to provide detailed safety and efficacy ... September. The MATRIX trial, a prospective, randomized, double-blind, placebo-controlled ...
... , , SUNRISE, Fla., July ... to delivering intelligent devices and biologics that help monitor, diagnose and ... FDA cleared a phase I clinical trial for MyoCell SDF-1 (Stromal ... REGEN trial will enroll 15 patients in a multicenter, randomized, dose ...
... , , CINCINNATI, July 27 ... full-service clinical research organization, today appointed Stephen Cutler, PhD, as ... (COO) effective immediately. Dr. Cutler brings to Kendle more than ... the CRO and biopharmaceutical industries to position the Company for ...
Cached Biology Technology:Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 2Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 3Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 4Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 5United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients 2United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients 3United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients 4Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer 2Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer 3